Jie-Fu Chen Profile
Jie-Fu Chen

@JieFuChen2

Followers
103
Following
50
Media
0
Statuses
28

Assistant Attending, specialized in Genitourinary and Molecular Pathology #GUPath #MSKpathology

Joined August 2020
Don't wanna be here? Send us removal request.
@MSKPathology
MSK Department of Pathology & Laboratory Medicine
4 months
Come Join Our Team!! MSKCC GU Pathology is recruiting applicants to our 2027-28 #GUpath fellowship ✔️Diverse case mix & volume from all GU organs ✔️ Excellent research opportunities ✔️ Teaching & learning from dedicated GU pathologists with a wealth of experience Details👇🏻
1
7
20
@rovingatuscap
Samson W. Fine, MD
1 year
1/ New article online in @ModernPathology from @MSKCancerCenter #gupath team led by Drs. Benzi Samueli & Jie-Fu Chen @JieFuChen2 Histopathologic and Molecular Characterization of IDH-Mutant Prostatic Adenocarcinoma (takeaways👇🏻) #ProstateCancer https://t.co/yK7WPjcisg
1
21
52
@rovingatuscap
Samson W. Fine, MD
3 years
Had a most wonderful time celebrating #gupath community at Grawitz dinner Sunday evening 3/12 #USCAP2023 - here with @MSKPathology faculty, former fellows, & friends
1
3
43
@rovingatuscap
Samson W. Fine, MD
3 years
The Stewart Award 🥇 presentation @MSKPathology Alumni gathering is preceded by topical talks related to the work of the Awardee Here, Dr. Satish Tickoo presents on Neuroblastoma staging & classification, specifically on ‘stroma-rich’ tumors, including GNB, intermixed
1
6
18
@rovingatuscap
Samson W. Fine, MD
3 years
Dr. Shakeel Modak, Chief of the Neuroblastoma Service @MSKCancerCenter educating us on risk assessment in the disease & challenges/opportunities with #immunotherapy in High Risk #neuroblastoma
0
5
10
@rovingatuscap
Samson W. Fine, MD
3 years
Dr. Shimada highlighting the importance of Favorable vs. Unfavorable Histology in determining risk in #neuroblastoma @MSKPathology Fred W Stewart Award🥇Lecture #pathology #pedipath
0
4
9
@h_alahmadie
Hikmat Al Ahmadie
3 years
Do you want to learn about everything urothelial carcinoma with divergent differentiation and variant histology (or shall we say subtypes!) Here is a link with 50 days' free access https://t.co/E9YeCRlq2r
6
21
73
@rovingatuscap
Samson W. Fine, MD
3 years
Excited to highlight new work @Histo_Journal led by Dr. Anu Gopalan @MSKPathology Clinicopathologic characterization [see pic] of neuroendocrine (NE) differentiation in setting of prostatic carcinoma (PCa) https://t.co/Sioa1YL6dj #gupath #prostatecancer #neuroendocrine 1/
2
12
20
@rovingatuscap
Samson W. Fine, MD
4 years
Always a privilege to join with Dr. Reuter and a generation worth of @MSKPathology #gupath fellows #USCAP2022
1
8
37
@LaraHarikMD
Lara Harik MD
4 years
Unusual and super rare case: What is your diagnosis? Older woman Stain is NKX3.1, also positive for PSA #GUPATH #GYNPATH #pathology #PathTwitter
33
158
353
@GU_Path_Society
GU Pathology Society (GUPS)
4 years
1st GUPS Virtual Education Series event Genitourinary Pathology WHO Updates The Latest on Renal, Urothelial, & Testicular tumors Featuring Drs. Ondrej Hes, Eva Comperat, and Daniel Berney Tuesday January 25, 2022 12-1:15pm EST Registeration: https://t.co/ooia8IWGlA
0
37
64
@GSRGTPath
GSRGT Pathology
4 years
Thank u @h_alahmadie and @henning_reis 4 organizing the outstanding webinar: Urinary Tract Diagnostic Challenges and Therapeutic Update Thanks to the expert speakers without whom this could not happen ✅ https://t.co/Zh58YzwvJU for recording (coming soon) #GUPATH #PathTwitter
2
9
25
@Shounak_Gupta
Sounak Gupta
4 years
Todays case. Prostate.
3
28
61
@GU_Path_Society
GU Pathology Society (GUPS)
4 years
Check out GU educational videos posted in GUPS website. More to come! https://t.co/QqZmPsgYi0 #gupath #pathology
0
3
3
@DrMahul
Dr. Mahul Amin
4 years
At least 12/22 distinctive renal tumors may have a low grade oncocytic morphology that often requires clinical information and additional IHC or molecular studies. Join me tomorrow 8/14 @ 12ET as I discuss my “Approach to Eosinophilic tumors of the Kidney” in a livestreamed class
3
43
104
@rovingatuscap
Samson W. Fine, MD
4 years
…and…1st in person #gupath Consensus Conference @MSKPathology since early March 2020 (hybrid option included) @MoHumrani @behtashg @BinXu16 @Unclassified1 @h_alahmadie
4
10
88
@VarshaManuchaMD
Varsha Manucha, MD
5 years
Next #GUPathJC March 23rd 8PM EST Special guest Dr. Hikmat Al Ahmadie @h_alahmadie ? PUNLMP as a separate grade category in Ta tumors ? Paper - https://t.co/faN4aCZo7f @GU_Path_Society @rovingatuscap @Shounak_Gupta @LaraHarikMD @lalpritu @LiangChengMD @rajalbshah
4
9
25
@JieFuChen2
Jie-Fu Chen
5 years
Truly a great honor for me, and the honor also goes to the GU team at @MSKpathology; can't be more grateful for everything I have learned here. Special thanks to Dr. Yingbei Chen @Unclassified1 and Dr. Liwei Jia @liwei_jia for this wonderful opportunity.
@GU_Path_Society
GU Pathology Society (GUPS)
5 years
Congratulations to @GU_Path_Society Best Abstract Awardees Dr. Thomas Denize @anotherpathres Dr. Jie-Fu Chen @JieFuChen2 Dr. Harsimar Kaur @harsimarbhatia https://t.co/h1h7WrZuUB #gupath #USCAP2021VNI #USCAP2021
1
2
5
@rovingatuscap
Samson W. Fine, MD
5 years
RCC w/prominent fibromuscular stroma (RCC-FMS): tumor nodules w/ elongated, branching tubules variably papillary architecture voluminous clear/pale pink cytoplasm ✴️separated by variable fibromuscular stroma #gupath #kidneycancer #KidneyCancerAwarenessMonth 2/
1
11
26
@GU_Path_Society
GU Pathology Society (GUPS)
5 years
@GU_Path_Society Companion Meeting #USCAP2021VNI (Virtual 'N Interactive) “Digital Pathology & Artificial Intelligence in #gupath : Present & Future Perspective” LIVE Q&A w/faculty: Th 3/18: 9:45-10:15AM PT ✴️To access recorded presentations, register for the USCAP meeting
0
8
17